1.
Papp KA, Blauvelt A, Flack M, Gu Y, Thompson EH. Clinical Responses in Patients with Moderate-to-Severe Plaque Psoriasis Following Withdrawal and Re-Treatment with Risankizumab or Switching from Ustekinumab to Risankizumab. J of Skin [Internet]. 2017Oct.27 [cited 2022Aug.15];1(3.1):s5. Available from: https://jofskin.org/index.php/skin/article/view/77